Impact of Dehydroepiandrosterone Sulfate on Newborn Leukocyte Telomere Length

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Liu, Han ^a   Zhou, Guangdi ^a   Chen, Qian ^a   Ouyang, Fengxiu ^a   Little, Julian ^b   Zhang, Jun ^a   Chen, Dan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; HYDROCORTISONE; PRASTERONE SULFATE; REACTIVE OXYGEN METABOLITE;

BLOOD; CHEMISTRY; FEMALE; FETUS BLOOD; GESTATIONAL AGE; HUMAN; LEUKOCYTE; MALE; METABOLISM; NEWBORN; PREGNANCY; PROSPECTIVE STUDY; TELOMERE; TELOMERE HOMEOSTASIS; ULTRASTRUCTURE;

DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; LEUKOCYTES; MALE; PREGNANCY; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 85012216752     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42160     Document Type: Article

References (34)

1. Moyzis, R. K. et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85, 6622-6626 (1988).
2. Greider, C. W. Telomeres and senescence: the history, the experiment, the future. Curr Biol 8, R178-181 (1998).
3. Weng, N. P. Telomeres and immune competency. Curr Opin Immunol 24, 470-475 (2012).
4. Jaskelioff, M. et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469, 102-106 (2011).
5. Sahin, E. et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470, 359-365 (2011).
6. Sahin, E. & Depinho, R. A. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464, 520-528 (2010).
7. Zhu, H., Belcher, M. & van der Harst, P. Healthy aging and disease: role for telomere biology? Clin Sci (Lond) 120, 427-440 (2011).
8. Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A. & Kerber, R. A. Association between telomere length in blood and mortality in people aged 60 years or older. The Lancet 361, 393-395 (2003).
9. Shalev, I. et al. Stress and telomere biology: a lifespan perspective. Psychoneuroendocrinology 38, 1835-1842 (2013).
10. Entringer, S., Buss, C. & Wadhwa, P. D. Prenatal stress, telomere biology, and fetal programming of health and disease risk. Sci Signal 5, pt12 (2012).
11. Menon, R. et al. Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS One 7, e31136 (2012).
12. Entringer, S. et al. Maternal psychosocial stress during pregnancy is associated with newborn leukocyte telomere length. Am J Obstet Gynecol 208, 134 e1-7 (2013).
13. Salihu, H. M. et al. Impact of intrauterine tobacco exposure on fetal telomere length. Am J Obstet Gynecol 212, 205 e1-8 (2015).
14. Aviv, A.Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med (Berl) 80, 689-695 (2002).
15. von Zglinicki, T. Oxidative stress shortens telomeres. Trends Biochem Sci 27, 339-344 (2002).
16. Kawanishi, S. & Oikawa, S. Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci 1019, 278-284 (2004).
17. Oikawa, S. & Kawanishi, S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 453, 365-368 (1999).
18. Y. Iwasaki, M. Asai, M. Yoshida, T. Nigawara, M. Kambayashi & N. Nakashima Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab 89, 3449-3454 (2004).
19. MacEwen, E. G. & Kurzman, I. D. Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA). J Nutr 121, S51-55 (1991).
20. Barrett-Connor, E., Khaw, K. T. & Yen, S. S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315, 1519-1524 (1986).
21. Schwartz, A. G., Pashko, L. & Whitcomb, J. M. Inhibition of tumor development by dehydroepiandrosterone and related steroids. Toxicol Pathol 14, 357-362 (1986).
22. Casson, P. R. et al. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 169, 1536-1539 (1993).
23. Morales, A. J., Nolan, J. J., Nelson, J. C. & Yen, S. S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78, 1360-1367 (1994).
24. Berr, C., Lafont, S., Debuire, B., Dartigues, J. F. & Baulieu, E. E. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA 93, 13410-13415 (1996).
25. Migeon, C. J., Keller, A. R., Lawrence, B. & Shepard, T. H. 2nd. Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; day-to-day and diurnal variations. J Clin Endocrinol Metab 17, 1051-1062 (1957).
26. Orentreich, N., Brind, J. L., Rizer, R. L. & Vogelman, J. H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59, 551-555 (1984).
27. Zumoff, B., Rosenfeld, R. S., Strain, G. W., Levin, J. & Fukushima, D. K. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 51, 330-333 (1980).
28. Schriock, E. D. et al. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metab 66, 1329-1331 (1988).
29. Ochedalski, T. & Lachowicz, A. Maternal and fetal hypothalamo-pituitary-adrenal axis: different response depends upon the mode of parturition. Neuro Endocrinol Lett 25, 278-282 (2004).
30. Aviv, A. et al. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic acids research 39, e134 (2011).
31. Cawthon, R. M. Telomere measurement by quantitative PCR. Nucleic Acids Res 30, e47 (2002).
32. Li, Q. et al. A possible new mechanism in the pathophysiology of polycystic ovary syndrome (PCOS): the discovery that leukocyte telomere length is strongly associated with PCOS. J Clin Endocrinol Metab 99, E234-240 (2014).
33. Wadhwa, P. D. et al. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol 191, 1063-1069 (2004).
34. Davy, P., Nagata, M., Bullard, P., Fogelson, N. S. & Allsopp, R. Fetal growth restriction is associated with accelerated telomere shortening and increased expression of cell senescence markers in the placenta. Placenta 30, 539-542 (2009).